OK SB693

Amends 63 O.S. 2011, Section 2-309D to modify access provisions for confidential central repository information collected under the Anti-Drug Diversion Act.

Permits access to central repository information by certified peace officers, DEA Diversion Group Supervisor, executive directors/chief investigators of specified professional boards (pharmacy, medical, dental, veterinary, podiatric, osteopathic, health), multicounty grand juries, and the Departments of Mental Health and Substance Abuse Services and State Health for statistical and research purposes.

Requires medical practitioners and their staff to access and verify central repository information prior to prescribing or authorizing refills of hydrocodone, oxycodone, benzodiazepines, diazepam, carisoprodal, or ultram to assess medical necessity and prevent unlawful drug acquisition.

Establishes that nonfatal overdose information remains strictly confidential and accessible only to the Bureau of Narcotics Director or designee, the Chief Medical Examiner, and the reporting registrant, with registrants protected from liability for reported information.

Requires medical examiners to report decedent names and dates of birth to the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control upon completion of investigations determining death by controlled substance overdose, with the Bureau maintaining a database of prescribing medical practitioners.

Becomes effective November 1, 2015.